• Font Size    
E-mail

Close Window E-mail This Page

Court Takes Up Suit Over Muscular Dystrophy Drug

Required fields are marked with an asterisk(*)



The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +   

Court Takes Up Suit Over Muscular Dystrophy Drug

WASHINGTON (AP) ― A federal court in New Jersey is scheduled to take up a Minnesota family's lawsuit Tuesday seeking access to an experimental drug for a fatal form of muscular dystrophy.

Jacob Gunvalson and his parents want PTC Therapeutics of South Plainfield, New Jersey, to provide him with the drug, PTC124. The family claims that the company promised them Jacob would have access to the drug but then broke its word. The company denies making that assurance.

Jacob suffers from Duchenne muscular dystrophy, a genetic, degenerative disease that mostly affects young boys. Typically, those who suffer from it die in their 20s because of weakness in their heart and lung muscles. The family says that without PTC124, Jacob will die.



(© 2009 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)